1 Department of Psychological & Brain Sciences, Boston University, Boston, MA, USA.
2 Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA.
Aust N Z J Psychiatry. 2018 Sep;52(9):847-855. doi: 10.1177/0004867418788172. Epub 2018 Jul 26.
Up to 60% of patients with bipolar disorder develop a substance use disorder during their lifetime. The purpose of this paper was to assess the impact of substance use disorders on depression recovery among bipolar patients randomly assigned to different psychotropic medications and psychosocial interventions. We hypothesized that patients with a comorbid substance use disorder would benefit less from psychotherapy regardless of treatment intensity/length compared to patients without a comorbid substance use disorder.
We conducted post hoc analyses among bipolar disorder patients ( n = 270) with and without comorbid substance use disorders enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder randomized psychosocial intervention trial. All patients entered during or shortly after the onset of a bipolar depressive episode. Logistic regression and Cox proportional hazard models were used to assess whether current or past substance use disorders moderated the response of patients to intensive psychosocial intervention or brief psychoeducation with collaborative care, operationalized as full recovery from an episode of bipolar depression.
Current comorbid substance use disorders significantly predicted likelihood of recovery (odds ratio = 2.25, p = 0.025) and time to recovery (odds ratio = 1.71, p = 0.006) from bipolar depression. We found that 74.5% of patients with a current substance use disorder, compared to 56.5% without a current substance use disorder, recovered from bipolar depression. Past substance use disorders did not predict likelihood of recovery or time to recovery. Current substance use disorders did not significantly moderate response to intensive psychotherapy versus collaborative care.
Contrary to our hypotheses, bipolar disorder participants with a current comorbid substance use disorder were more likely to recover from psychosocial treatment for bipolar depression than patients without a current comorbid substance use disorder. If this finding is replicated, it has implications for the ordering of treatment for patients with comorbid bipolar disorder and substance use disorders.
多达 60%的双相情感障碍患者在其一生中会发展出物质使用障碍。本文旨在评估物质使用障碍对随机分配到不同精神药物和心理社会干预措施的双相患者抑郁康复的影响。我们假设,与没有共病物质使用障碍的患者相比,共病物质使用障碍的患者无论治疗强度/长度如何,都不太可能从心理治疗中受益。
我们对参加系统性治疗增强计划治疗双相情感障碍随机心理社会干预试验的有和没有共病物质使用障碍的双相情感障碍患者(n=270)进行了事后分析。所有患者均在双相抑郁发作期间或之后不久入组。使用逻辑回归和 Cox 比例风险模型来评估当前或过去的物质使用障碍是否调节了患者对强化心理社会干预或简短心理教育联合合作护理的反应,即从双相抑郁发作中完全康复。
当前共病物质使用障碍显著预测了患者从双相抑郁中康复的可能性(优势比=2.25,p=0.025)和康复时间(优势比=1.71,p=0.006)。我们发现,74.5%的当前物质使用障碍患者,与没有当前物质使用障碍的患者相比,从双相抑郁中康复。过去的物质使用障碍与康复的可能性或康复时间无关。当前的物质使用障碍并未显著调节强化心理治疗与合作护理的反应。
与我们的假设相反,当前共病物质使用障碍的双相情感障碍患者比没有当前共病物质使用障碍的患者更有可能从双相情感障碍的心理社会治疗中康复。如果这一发现得到复制,它将对共病双相情感障碍和物质使用障碍患者的治疗顺序产生影响。